According to emerging evidence, apocrine carcinomas tend to show estrogen and progesterone receptor negativity and androgen receptor positivity (ER−/PR−/AR+); and expression of Gross cystic disease protein fluid-15 (GCDPF-15) [3, 4]. This evidence concerns the gene AR and apocrine adenocarcinoma.